NewsBenzingaPDS生物技术宣布在美国医学协会的同行评审期刊《JAMA肿瘤学》上发表了PDS0101与Pembrolizumab联合治疗HPV16靶向免疫疗法的II期试验结果 PDS生物技术宣布在美国医学协会的同行评审期刊《JAMA肿瘤学》上发表了PDS0101与Pembrolizumab联合治疗HPV16靶向免疫疗法的II期试验结果 Benzinga 2026.09.22 12:08 (GMT+0) Open on Benzinga Other news Barclays Maintains Equal-Weight on Exelon, Lowers Price Target to $44 The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition. Citizens Financial Analysts Slash Their Forecasts Following Q3 Results Barclays Maintains Overweight on Evergy, Lowers Price Target to $86 Mastercard Brings Its Fraud-Fighting Tools to Stablecoin Payments Barclays Maintains Overweight on Entergy, Lowers Price Target to $115
The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition.
